Medical network - December 30, 2016, a series of New Deal, the pharmaceutical industry challenges and opportunities coexist. Dividend policy, accelerate industry consolidation, medicine back in 2016, what are the highlights? How the pattern of "churning" industry?
"Joining together of two bao" acceleration
Policy review: on January 12, the state council issued by the "about the opinions of the integration of urban and rural residents basic medical insurance system", the integration of the basic medical insurance for urban residents and the two new type of rural cooperative medical care system, establish a unified urban and rural residents basic medical insurance system request "six unification", the region as a whole to a concrete implementation plan prior to the end of December 2016.
Comments: "six unification" has been clear about the specific scope of consolidation, financing policy, unified ensures treatment, for the nationwide "joining together of two bao" set "road map". "Joining together of two insurance" will break the state of health care market fragmentation, for a long time for the next step of basic medical insurance for urban residents, the new rural cooperative medical treatment, medical insurance for urban employees create the timing of the unity of miho.
Stop drug electronic supervision code
Policy review: on February 20th, state food and drug supervision bureau issued a statement on suspended 1 2015 drug electronic monitoring to the relevant provisions of the notice, decided to suspend execution state food and drug supervision administration of pharmaceutical production enterprise parties on matters relating to the full implementation of the pharmaceutical electronic regulatory announcement no. 1 (2015) of the relevant provisions of the drug electronic monitoring.
Comments: in January this year, hunan's days and large pharmacy enterprise group co., LTD., the state food and drug supervision and management of the administration to court, think "enforce administrative illegal drug electronic supervision code", caused widespread concern. Will perform drug electronic monitoring code to perform drug traceability, avoid the repeated construction, enterprise resources is conducive to implement enterprise's main body responsibility, more in line with the actual.
"Generics consistency evaluation"
Policy review: on March 5, issued by the general office of the state council concerning the evaluation opinions of generics effect quality and consistency, and classification of chemical new registered approval prior to implementation of generics, who is not in accordance with the principle of in line with the original drug quality and curative effect of examination and approval, shall be in consistency.
Review: for a long time, because of the lack of consistency evaluation mechanism, our country some generic and branded drug obvious gap, a move that will promote the generics are consistent with the original drugs on curative effect, to ensure the safety of drugs, enhance the overall level of China's pharmaceutical industry.
"Two votes" to promote industry "shuffle"
Policy review: on April 26, the state council general office issued by the deepening medical and health system reform in 2016 key task "clear, comprehensive reform pilot provinces throughout the province to implement the" two votes ", encourage hospital and pharmaceutical production enterprise direct settlement drugs, pharmaceutical production enterprise and distribution enterprise settlement distribution costs, the compression of the intermediate links, reduce prices artificially high.
Comments: "two votes" pilot, will cut layer upon layer, layer upon layer of make out an invoice price of chain drug prices artificially high "interests, extrusion callings, walk, gray" moisture ", purify the drug circulation market, promote the development of medicine market healthy mature.
Drug marketing authorisation holder system pilot
Policy review: on June 6, the state council general office issued by the "drug marketing authorisation holder system pilot scheme", in Beijing, sichuan and other 10 provinces (municipalities) to carry out the pilot work. "Plan" put forward, the pilot drug research and development institutions or researchers in administrative area can be used as a drug registration applicant submit an application for drug clinical trials and drug applications, the applicant obtained a drug approval number authorisation and can be a drug marketing authorisation holder.
Comments: remove "bundling" drug registration and production permits, to encourage drug research and development innovation, avoid low-level redundant construction. But licensor is a kind of new things for our country, on the one hand, need to open inclusive mentality to encourage first try; On the other hand the more it actually realized specific operation level. Become a marketing authorisation holder is a very complicated process, in the concrete execution will meet all kinds of complicated situations, formulate operational rules need to be speed up.
Promote the reform of medical service prices in an all-round way
Policy review: on July 1st, the national development and reform commission and the national health and family planning commission, the ministry of human resources and social security, the ministry of finance issued "about print and distribute the opinions of promote the reform of the medical service price notice. "Opinions" clear, the medical service price to the categorized management, the public medical institutions to provide basic medical services of the government pricing; The public medical institutions to provide medical services, the implementation of market regulation policy.
Comment on: comprehensively promote the reform of the medical service price, change for a long time the distortion of the medical service price system, establish a scientific and reasonable compensation mechanism of medical institutions, to promote public hospital return to public welfare, stimulate the vitality of the public hospital development.
Medical insurance directory readjustment after seven years
Policy review, September 30, the ministry of human resources and social security issued on the 2016 national basic medical insurance, inductrial injury insurance and maternity insurance drug catalogue work adjustment plan (draft) "public notification for advice. "Draft" mentioned in the health care medicine directory adjustment is done before the end of 2016 work, improve the basic measures for the management of health care medicine, 2017, gradually establish a standardized drug catalogue dynamic adjustment mechanism.
Comments: it is seven years since 2009, the medical insurance directory adjustment to start again. Children's medicine, performances and expensive medicine and major disease medication is expected to be more call directory, is good for patients, Chinese pharmaceutical market pattern will be different.
"Healthy China" planning
Policy review: on October 25, the state council issued the "healthy China 2030" planning outline, outline highlighted three key contents: one is prevention, 2 it is adjusting and optimizing health service system, three is to "co-construction and sharing Universal health "as the strategic theme, the realization of the national health.
Comments: "healthy China" a great health planning pattern, pointed out the direction of the establishment of the future will change the current pattern is given priority to with treatment of medical treatment, prevention of social health consensus, at the same time, will also produce earth-shaking changes to the medicine.
Public hospitals to security administration "accelerated"
Policy review: on November 8, the general office of the central committee of the communist party of China and the state council on forwarding the deepening medical and health system reform leading group of the state council on further promoting the deepening medical and health system reform experiences of the several opinions, put forward to promote separating, pipe run separately, to establish modern hospital management system, establish the personnel salary system in accordance with industry characteristics, arouse the enthusiasm of the medical staff.
Comments: as the main reform, reform of public hospitals has always been a piece of "hard stuff". This is a public hospital to security administration "accelerated" a signal, the operation mechanism of public hospital "separated" is imperative.
The law of traditional Chinese medicine
Policy review: on December 25, the 12th session of the standing committee of the National People's Congress meeting of 25 approved by the vote of the People's Republic of China law of traditional Chinese medicine, this is the first method of traditional Chinese medicine in China, a milestone in the development of industry of Chinese medicine. The law since July 1, 2017.
Comment on: finally "laws" of traditional Chinese medicine, have a legal "rely on". This is a great event for medicine, folk is expected to obtain "certification" of traditional Chinese medicine, Chinese medicine will be more standardized, reliable and conducive to the long-term development of Chinese medicine in China. |
